Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) EBT (2018 - 2025)

Viemed Healthcare (VMD) has disclosed EBT for 6 consecutive years, with $8.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 26.99% year-over-year to $8.0 million, compared with a TTM value of $21.8 million through Dec 2025, up 34.61%, and an annual FY2025 reading of $21.8 million, up 34.61% over the prior year.
  • EBT was $8.0 million for Q4 2025 at Viemed Healthcare, up from $5.1 million in the prior quarter.
  • Across five years, EBT topped out at $8.0 million in Q4 2025 and bottomed at $1.4 million in Q2 2022.
  • Average EBT over 5 years is $3.7 million, with a median of $3.4 million recorded in 2021.
  • The sharpest move saw EBT plummeted 77.97% in 2021, then surged 180.54% in 2023.
  • Year by year, EBT stood at $5.1 million in 2021, then decreased by 29.1% to $3.6 million in 2022, then soared by 41.63% to $5.1 million in 2023, then rose by 24.21% to $6.3 million in 2024, then increased by 26.99% to $8.0 million in 2025.
  • Business Quant data shows EBT for VMD at $8.0 million in Q4 2025, $5.1 million in Q3 2025, and $5.0 million in Q2 2025.